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ABSTRACT 
The release of extracellular vesicles such as exosomes provides an attractive intercellular 
communication pathway. Exosomes are 30-150 nm membrane vesicles that originate in endosomal 
compartment and act as intercellular mediators in both physiological and pathological context. Despite 
of the growing interest in exosome functions, the mechanisms responsible for their biogenesis and 
secretion are still not completely understood. This knowledge is yet capital as it controls the 
composition, and hence the function, and the secretion of exosomes. Exosomes are produced as 
intraluminal vesicles (ILVs) in very dynamic endosomal organelles that undergo various maturation 
processes in order to form multivesicular endosomes. The function of multivesicular endosomes will 
notably be balanced between exosome secretion and lysosomal degradation. In this review, we 
present and discuss each intracellular trafficking pathways that have been reported or proposed to 
regulate exosomes biogenesis with a particular focus on the importance of endosomal dynamics in the 
sorting of protein cargoes to exosomes and the secretion of multivesicular endosomes. A global 
picture reveals several key mechanisms that act mainly at crossroads of endosomal pathways acting 
as regulatory checkpoints of exosome biogenesis. 
 
Summary Points: 
. Biogenesis of exosomes is regulated by various checkpoints that scattered the endosomal pathway. 
. A first checkpoint regulates the targeting of exosomal cargoes from the plasma membrane to the 
multivesicular endosome. 
. A second checkpoint allows the sorting of cargoes to intraluminal vesicles of multivesicular 
endosomes via several sorting mechanisms that influence the fate of the compartment. 
. A third checkpoint controls the balance between the secretion and the degradation of multivesicular 
endosomes. 
. The intracellular pathways involved in exosome biogenesis are determinant for their function as they 
regulate the composition, the polarized release and the fate of exosomes. 
 
ABBREVIATIONS LIST 
Extracellular vesicles (EV), intraluminal vesicles (ILVs), multivesicular endosome (MVE), ADP-
ribosylation factor 6 (Arf6), Endosomal Sorting Complex Required for Transport (ESCRT), Epstein-
Barr virus (EBV)-encoded latent membrane protein 1 (LMP1), post-translational modification (PTM), 
tetraspanin 6 (TSPAN6),  
 
INTRODUCTION 
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All cells, from bacteria to human, release different types of extracellular vesicles (EV), that can be 
taken up by nearby or distant cells and modulate their activity. Hence, EVs can act as intercellular 
mediators in many physiological and pathological situations, including development, physiological 
communication (e.g. neurons, skin), immune response, cancer progression and metastasis, 
cardiovascular and neurodegenerative diseases(1). The origin, nature, size and content of these 
vesicles are diverse. Despite of the use of many different terminologies to identify EVs in the literature 
and a nomenclature that is still a matter of debate, two main classes of extracellular vesicles can be 
identified: microvesicles and exosomes(2). Microvesicles are generated by outward budding and 
fission of the plasma membrane and the subsequent release of these vesicles into the extracellular 
space(3). Their size ranges usually from 50 to 1000 nm in diameter, but can become larger (up to 10 
µm) in the case of oncosomes. Exosomes originate as intraluminal vesicles (ILVs) by inward budding 
of the limiting membrane of maturing endosomes usually referred as multivesicular endosome (MVE) 
or multivesicular body (MVB). MVEs are able to fuse with the plasma membrane and release ILVs 
from 30 to 150 nm in diameter(4)
 
in the extracellular environment as exosomes. While an increasing 
number of studies investigated the roles of EVs in cell-cell communication, less attention has been 
paid to the mechanisms involved in their biogenesis(5) and how they are regulated to modulate EVs 
secretion in producing cells.  
In this review, we will only focus on exosome biogenesis and the generation and secretion of MVEs 
(further details on microvesicle generation can be found in more detailed review(3)). MVEs are part of 
the endosomal pathway that allows protein cargoes to be either recycled or degraded after their 
internalization(6). Therefore, MVEs cannot only be considered as the site of generation of the future 
exosomes but as a dynamic maturing compartment with various functions that results from the 
coordination of multiple intracellular molecular mechanisms. The endosomal pathway is scattered with 
several crossroads allowing either the recycling of protein cargoes to the plasma membrane or the 
Golgi apparatus or their sorting to ILVs.  MVEs form then a crossroad that will target cargoes sorted 
on ILVs either to secretion or to lysosomal degradation.  Each sorting step in the endosomal pathway 
can be viewed then as a regulatory checkpoint. As a consequence, that the different mechanisms 
involved in exosome biogenesis, from the intracellular trafficking of cargoes to MVE including their 
sorting into ILVs to the targeting of MVEs toward the plasma membrane instead of toward lysosomes 
act as regulatory elements of exosomes biogenesis. We will discuss how each step of the endosomal 
pathway can influence exosome biogenesis with a particular focus on the balance between endosomal 
degradation and secretion.  
 
EXPRESSION OF CARGOE AS FIRST REGULATORS OF EV BIOGENESIS 
 
Cargoes destined for exosomal secretion can be viewed as the first regulators of exosome formation 
as the presence of a particular cargo at MVEs can induce the recruitment of specific machineries that 
will lead to ILVs formation. This idea is supported by the observation that ectopic expression of MHC 
Class II in HeLa cells(7) or its forced expression in intestinal epithelial cells after stimulation by γIFN or 
expression of its transactivator CIITA increased the release of extracellular vesicles (8). This 
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increased secretion can be attributed to the increased generation of MVEs and the recruitment of 
sorting machineries by the cargoe that will promote ILV (or future exosomes) generation. Expression 
of another exosomal cargoe, PMEL, a specific melanosomal protein, in Hela cells induces indeed its 
sorting to ILVs by recruitment of specific sorting mechanisms(9) and generation of subpopulations of 
ILVs (10) and the production of exosomes (G. van Niel unpublished data) (10)(11). Similarly, 
overexpression and depletion of syndecan from MCF-7 cells respectively increase and decrease the 
recovery of exosomal markers (12). In this context, the regulation of the expression of a given cargo, 
which is either cell type specific or induced by external stimuli, is the first regulatory elements that will 
modulate exosome biogenesis. It should be noted that a default of exosome secretion could then 
reflect an impaired expression of exosomal cargoe. It could also result from an inhibition of MVE 
secretion or a defect of ILV generation. To avoid such misinterpretation, cargo expression, exosome 
recovery and exosome generation as ILVs in MVE should be investigated in parallel. As well, isolation 
and investigation methods used for the study of EVs can lead to the selection or the enrichment of a 
given subpopulation of exosome
 
(13). Therefore, a particular attention should be given to the methods 
and the cellular models employed in each study to clearly conclude on a defect of ILV generation or of 
MVE secretion.  
 
TARGETING CARGOES TO MULTIVESICULAR ENDOSOMES 
To be secreted on exosomes, cargoes need to reach the endosomal pathway before being sorted to 
intraluminal vesicles. Muted version of PLP retained in the Endoplasmic reticulum, for example, are 
unable to reach the endosomal pathway and are not secreted on exosomes (14). Exosomal 
membrane cargoes can reach endosomes by being internalized from the plasma membrane or by 
direct targeting from the Golgi apparatus.  
Known cargoes of exosomes such as PMEL (9) or APP (15) are first transported to the plasma 
membrane from where they are internalized to reach endosomes.  Endocytosis of proteins can involve 
different pathways. The most studied is clathrin-dependent endocytosis, which requires the 
polymerization of a clathrin coat on the cytoplasmic face of curved plasma membrane and the 
subsequent invagination and scission of the vesicles, with this last step mediated by the GTPase 
dynamin
 
(16). This pathway is notably employed by mature MHC II to reach Arf6
+
Rab35
+
EHD1
+
 
tubular endosomes (17) and by EGFR (18). Of note, such endocytosis is dependent on ubiquitination 
of the cargoes (19),(20) that targets them to degradation and not exosomal secretion. Other pathways, 
defined as “clathrin- independent endocytosis” (CI), include caveolae vesicular mediated endocytosis 
(also dynamin dependent) and the clathrin- and dynamin-independent carriers (CLICs) tubular 
intermediates (21).  Such pathways allow internalization of different cargoes such as CD44 and GPI-
anchored protein (22)(23) or Galectin 3 (24) that are all found on exosomes. The relevance of CI 
pathway in the exosomal targeting of these cargoes is not proven yet although small GTPases such 
as the ADP-ribosylation factor 6 (Arf6) and Rho subfamilies members RhoA and Cdc42, which have 
been implicated in regulating different pathways of CI endocytosis, are all found in extracellular 
vesicles and Arf6 and Cdc42 were found to modulate exosomes and microvesicles secretion (25), 
(26), (27). Finally, flotillins, which are commonly used as exosome markers, can regulate the 
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endocytosis of specific cargoes, but the underlying mechanisms are still poorly understood. Flotillins 
may favor the clustering of the cargoes, therefore promoting their endocytosis that in some cases 
may require the presence of clathrin
 
(28). All these internalization pathways will deliver their cargoes 
to early endosomes (EE)
 
(6) providing a first checkpoint to target cargoes to MVEs and exosomes. 
Early endosomes appear as vacuolar compartments characterized by the presence of the small 
GTPase RAB5 from which thin tubular structures are pulled to generate recycling endosomes (RE). 
Cargoes targeted to recycling endosomes will be targeted back to the PM while cargoes destined to 
MVEs will accumulate on vacuolar subdomains of the EE and will be sorted into ILVs. Hence, cargoes 
that are destined for recycling to the plasma membrane will likely not be enriched in exosomes, unless 
their recycling is impaired as in case of transferrin receptor in reticulocytes (29). Such balance 
between recycling and targeting to MVE can be seen as a second checkpoint that will regulate 
exosome biogenesis. Among the proteins that regulate this crossroad between recycling and 
intraluminal sorting, the PDZ protein syntenin is an ideal suspect. In endosomes, syntenin interacts 
with syndecans and support their recycling to the plasma membrane trough a mechanism that 
requires the production of PI(4,5)P2 and the small GTPase Arf6 (30). Alternatively, syntenin, together 
with the ESCRT accessory protein ALIX, can dispatch syndecans to ILVs (12). Syndecans, syntenin 
and ALIX assemble in a tripartite complex that is able to drive not only their own exosomal release, but 
also the release of CD63 and HSP70. Interestingly, Arf6 and his effector PLD2 also control budding of 
ILVs and biogenesis of exosomes via the syndecan-syntenin-ALIX pathway
 
(27). Although it remains 
to be determined if recycling of syndecans affects directly syntenin-exosomes biogenesis, the fact that 
the same proteins play a role in both recycling and intraluminal sorting clearly illustrates the role of EE 
as the first “sorting station” of the cell, in which the fate of a cargo is primarily decided, and how this 
process needs to be tightly regulated. One could propose then that the “internalization” checkpoint 
and the “recycling” checkpoint, by regulating the localization of cargoes between the respective site 
of generation of exosomes and microvesicles, i.e. MVE or plasma membrane, may modulate a 
potential balance between exosome and microvesicle biogenesis. In this context, Arf6, by being 
involved in both exosome (27) and microvesicle (26) biogenesis, may control such balance between 
the generation of both subpopulations of EVs.  
Direct transport of proteins from Golgi to endo-lysosomal system has been mostly studied for the 
transport of lysosomal proteins. Transmembrane proteins possess a small amino acid motif (i.e., 
tyrosine- or dileucine-based motifs) that will be recognized by clathrin adaptor proteins allowing the 
formation of Golgi derived clathrin coated carriers that will then fuse with the endosomes (31).  The 
relevance of a direct transport from Golgi to MVEs and ILVs is illustrated by the protein GPRC5, a 
member of GPCR family proteins, which uses GGA1 carrier vesicles to be sorted on exosomes (32). 
Soluble proteins need to bind specific receptors (e.g. mannose phosphate receptor, sortilin) to be 
transported from Golgi apparatus to MVE. Once in endosome, the cargoes protein is released while 
the receptors usually recycle back to the Trans Golgi network by retrograde transport (31). Retrograde 
transport can then be seen as an alternative route from endosome that cargoes should avoid to end 
up in ILVs. This additional crossroad represents a third checkpoint that could be regulated by parkin, 
an E3 ubiquitin ligase that is found mutated in Parkinson’s disease (PD). Parkin would regulate such 
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balance between retrograde transport and targeting to ILVs by acting both on retrograde transport 
(through the retromer complex) and on inward budding and exosome secretion (33). Interestingly, 
sortilin, a receptor involved in anterograde transport from Golgi and a known cargoe of the retrograde 
transport (34) has also been shown to be secreted on exosomes and to modulate exosome 
biogenesis
 
(35), but the trafficking mechanisms underlying such regulation needs to be further 
investigated.  
 
 
ILV BIOGENESIS in MVEs 
Exosome biogenesis occurs in maturing endosomal compartment. Importantly, maturation of early 
endosomes into late endosomes requires switching of the RabGTPase RAB5 with RAB7 (6), which 
can be blocked by overexpression of a constitutively active mutant form of RAB5 (Q79L). This mutant 
induces fusion of early endosomes that are still able to form ILVs despite they appear enlarged (14). 
For this reason, RAB5 mutant expressing cells have been often used to visualize ILVs and to study 
the sorting of cargoes to ILVs (12) (14) (36)
 
(37). In addition depletion of RAB5 in Hela
 
(7) cells or 
RAB7 in MCF cells (12) (but not in Hela (7)) have been shown to modulate exosome secretion, 
although they may not have a direct role in exosome biogenesis but rather a global effect of 
endosome homeostasis. Of note, the precise step of maturation of MVE at which they would be 
preferentially secreted is still unknown. 
Within maturing endosome, likely concomitantly to Rab5/Rab7 switch, future exosomes are generated 
as ILVs through a process that requires the invagination and fission of the endosomal membrane to 
form an intraluminal vesicle. The first mechanism that was described for this process is the Endosomal 
Sorting Complex Required for Transport (ESCRT). ESCRT complex is composed by four different 
subcomplexes, ESCRT-0, -I, -II, -III and associated proteins such as ALIX, VTA1 and ATPase VPS4
 
(38). These subunits act together in a stepwise process that starts by the recruitment of ESCRT-0 at 
endosomal limiting membrane through ubiquitin moieties attached to the cytoplasmic domain of the 
transmembrane cargoes to sort. Importantly the cargoe (and Pi3P) will recruit the sorting machinery, 
strengthening the notion that the cargo is the first regulator of ILV biogenesis. ESCRT-0 and ESCRT-I 
will then cluster the cargoes under flat clathrin coat creating a subdomain of the endosomal membrane 
that will bud into ILV. The flat clathrin coat is thought to avoid cargoes diffusion and possibly their 
targeting to alternative pathways such as recycling or retrograde transport (39). This coat must be 
removed, potentially by the exosomes-enriched protein V-ATPase HSC70 (40) (41), to allow the 
recruitment of ESCRT-II and –III, the latter being responsible of membrane scission together with 
VPS4. During this process, ESCRT-III recruits deubiquitinating enzymes that remove ubiquitin tag 
from cargo proteins prior to the release of newly forming ILVs in the lumen of MVE. However, 
ubiquitinated proteins can be still found in exosomes suggesting that deubiquitination is not a critical 
step in exosome biogenesis
 
(42). Of note, the accessory protein ALIX, that intereact with the escrt-I 
subunit TSG101, provides an alternative route by recruiting directly ESCRT-III and VPS4 (12). 
The role of ESCRT machinery has been deeply investigated by Colombo et al. through RNA 
interference screen targeting of 23 ESCRT and ESCRT associated proteins in Hela cells and 
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identifying 7 proteins that affect exosome secretion
 
(43). While depletion of ESCRT-0 and I STAM, 
HRS and TSG101 reduced exosome secretion, depletion of ESCRT-III CHMP4C, VPS4, and 
accessory molecules VTA1 or ALIX increased exosome secretion. It should be noticed that, in the 
same study, depletion of ALIX increased MHCII secretion on exosomes but had variable effects on 
CD63 and HSC70 levels, suggesting that ALIX may affect more the composition of exosomes rather 
than global exosomal secretion. As the study was mainly focused on the analysis of exosomes once 
they were released from HeLa cells expressing the CIITA transactivator, it is still unclear which steps 
of exosome biogenesis were affected and whether it is specific to the forced expression of MHC II. But 
ESCRT-0 protein HRS has also been involved in exosome secretion in dendritic cells (44), in the 
release of exosomal Wnt3 (36)
 
and its depletion was shown to globally decrease exosomes number as 
measured by Nano particles tracking Analysis
 
(45). More recently, inhibition of VPS4 in HEK293 cells 
has been shown to decrease release of different subpopulation of EVs, corresponding to CD63 
enriched exosomes and CD9 enriched microvesicles (46). Interestingly, electron microscopy has 
shown that Hela cells depleted for HRS display MVBs containing small ILVs (below 40nm of diameter)
 
(10). It cannot be excluded then that, due to their small size, some subpopulations of exosomes are 
below the threshold of detection of some methods of investigation or still lack specific marker to be 
detected on western-blot. 
The ESCRT machinery can be partially (via ALIX) or completely dispensable for the generation of ILVs. 
ESCRT-independent biogenesis of ILVs was firstly revealed using simultaneous depletion of 
components of the four ESCRT subcomplexes
 
(47). Interestingly, electron microscopy has shown that 
ESCRT independent ILVs are enriched in the tetraspanin CD63 (10)
 
(47). Tetraspanins are a family of 
proteins with four transmembrane domains. Tetraspanins share a similar structure and organize as 
highly dynamic membrane microdomains called tetraspanin enriched microdomains (TEM), where 
tetraspanins interact with each other and with other transmembrane or cytosolic signaling proteins (48). 
Different tetraspanins have been proposed to have a role in ILVs formation. Bone marrow dendritic 
cells (BMDCs) from CD9 knockout mice secrete less exosomes compared to wild-type mice (49), 
while expression of CD9 and CD82 promote the release of β-catenin in exosomes
 
(49). In a mouse 
model of breast cancer, the release of Wnt11 on exosomes from cancer-associated fibroblast is 
dependent on tetraspanin CD81
 
(50). Expression of another tetraspanin, Tspan8 has been shown to 
change exosomal protein and mRNA content in rat adenocarcinoma cells
 
(51). Finally, the tetraspanin 
CD63, which is particularly enriched in exosome membranes, plays an important role in exosome 
biogenesis in multiple cell types. CD63 is required for the generation of small ILVs in Hela cells 
depleted for HRS
 
(10) and has been recently involved in the biogenesis of exosomes in fibroblasts 
from Down syndrome patients
 
(52). CD63 associates and targets Epstein-Barr virus (EBV)-encoded 
latent membrane protein 1 (LMP1) to ILVs and is critical for its secretion on exosomes
 
(53)
 
(54). In 
melanocytes, CD63 is required for the sorting of the melanosomal protein PMEL to ILVs (55), a 
process that involved the targeting of Apolipoprotein E to ILVs and exosomes but not the ESCRT 
machinery
 
(56).  
In addition to proteins, lipids have also been involved in exosome biogenesis. The first ESCRT-
independent mechanism reported for exosome biogenesis was identified in Oli-neu cells and requires 
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generation of the sphingolipid ceramide through hydrolysis of sphingomyelin by neutral type II 
sphingomyelinase
 
(14). Ceramide could create specific lipid microdomains and induce negative 
membrane curvature that will give rise to ILVs and exosomes enriched in ceramide. In addition a 
metabolite of ceramide, the sphingosine 1-phosphate, has recently been shown to continuously 
activate Gi-protein coupled sphingosine 1-phosphate receptor and to regulate in this way the sorting of 
cargoes into exosomal ILVs
 
(57). Exosomal membranes can also contain lipid rafts, specific lipid 
microdomains enriched in cholesterol and glycosphingolipids, which can contribute to ILV formation 
and sorting of raft-associated molecules such as Glycosyl PhosphatidyInositol (GPI)-anchored 
proteins
 
(58). In a similar way, the Ca
2+ 
-dependent phospholipid-binding protein Annexin A2 binds to 
lipid raft and is transported along the endocytic pathway where it is sorted into ILVs
 
(59). 
Diacylglycerol (DAG), another lipid second messenger, also seems to have a role in exosome 
formation. In fact inhibition of DGK, an enzyme that metabolizes DAG into phosphatidic acid has been 
shown to induce release of exosomes in T-cells
 
(60). Finally, bis(monoacylglyceryl)phosphate (BMP), 
formerly termed lysobisphosphatidic acid, (LBPA), is specifically enriched in late endosomes such as 
MVEs and can recruit ALIX to generate ILVs in vitro and in vivo (61). Phospholipase D (PLD), which 
hydrolyzes phosphatidylcholine to generate choline and phosphatidic acid, has also been involved in 
the generation of exosomes via the syntenin-ALIX pathway (27).   
Such proteolipid interactions, which are well known to induce membrane curvature (62), illustrate the 
interconnections between the multiple sorting machineries acting at MVEs. In this context, a recent 
structural study of the tetraspanin CD81 revealed a cone-like structure with an intramembrane pocket 
that can bind cholesterol (63). As proposed for the cone-shaped ceramide (14), clustering of several 
cone-shaped tetraspanins could then induce inward budding of these microdomaines. Another 
interrelationship between sorting mechanisms is illustrated by the known interaction of CD63 with 
syntenin (64), the regulation of CD63 by the Alix-syntenin pathway (12) and the formation of highly 
dynamic microdomain between different tetraspanins such as CD63, CD9 and CD81 (65) (13). 
Moreover, the syntenin-ALIX pathway in MCF (12) cells and the sorting of CD63 in HeLa cells (66) are 
both regulated by ceramide. But interconnections between the reported sorting machineries seems to 
be highly dependent on the cell type under investigation as the sorting of PMEL through ApoE, a 
soluble apolipoprotein with particular affinity for lipids, depends on CD63 but not on ESCRT or 
ceramide
 
(56) in pigment cells.  
Similar intersection or coordination also exists between ESCRT-dependent and –independent 
mechanisms. Non ubiquitinated cargoes can be trapped in microdomains formed by the clustering of 
highly ubiquitinated tetraspanin Cos. This ubiquitination “in trans” will allow the recruitment of the 
ESCRT machinery and “canonical” formation of ILVs in which non-ubiquitinated cargoes are also 
sorted (67). ESCRT-dependent and ESCRT-independent mechanisms for ILVs biogenesis are tightly 
coordinated at a single MVE in Pigment cells by the tetraspanin CD63 (55). ESCRT-dependent and 
ESCRT-independent mechanisms will give rise to a heterogeneous population of ILVs in term of size 
but also in term of cargoes (10). The variety of sorting mechanisms in a single cell type likely explains 
the heterogeneity in terms of size and composition of produced exosomes. 
 8 
Globally both ESCRT-dependent (at least ESCRT 0 and I that are also involved in syntenin-Alix 
pathway) and ESCRT–independent mechanism can participate at different extent in exosome 
biogenesis and provide a central checkpoint in this pathway. ESCRT-independent and semi-
dependent mechanisms seem nevertheless favoring ILVs release as exosomes while the conventional 
ESCRT dependent mechanism seems more dedicated to degradation.  
 
MODIFICATION OF CARGOES FOR THEIR SORTING TO EXOSOMES 
As main recruiters of sorting machineries at MVEs, any modification of cargoes fated to exosomal 
release may be determinant for their sorting and their release on exosomes. A major regulation of the 
sorting of proteins to exosomes is their post-translational modification (PTM). Interestingly, different 
PTM can compete to determine the fate of the same cargo
 
(68). A major PTM is ubiquitination that 
consists in the binding of ubiquitin moieties to cysteine present in the cytoplasmic domain of 
transmembrane protein or present and accessible on soluble proteins. Its role in the sorting of cargoes 
into ILVs destined for lysosomal degradation has been extensively studied and involved the 
recognition of the ubiquitinated cargoes (e.g. EGFR, MHCII) by ESCRT machinery. On the same line, 
ubiquitinated MHCII is targeted to MVEs fated for lysosomal degradation and sorted to ILVs likely 
through an ESCRT-dependent mechanism. Contrarily non ubiquitinated MHCII can be secreted on 
exosomes and its sorting to ILVs involves incorporation into CD9 containing membranes likely in an 
ESCRT-independent manner
 
(69). On the same line, exosomal secretion of SIMPLE
 
(70)
 
is enhanced 
after mutation of its binding site for ubiquitin ligase, suggesting that ubiquitination negatively regulates 
SIMPLE secretion on exosomes. This set of studies strengthens the notion that ESCRT-dependent 
and ESCRT-independent mechanisms are respectively associated with exosomes release and 
lysosomal degradation.  
Other PTM that can be important for the incorporation of cargoes in exosomes are addition of a small 
ubiquitin-related modifier (SUMO), as reported for heterogeneous nuclear ribonucleoprotein A2B1 
(hnRNPA2B1), a key regulator for the recognition of specific miRNAs and their loading into exosomes 
(71); phosphorylation, as in the case of Annexin A2
 
(59), and oxidation, as in the case of γ-synuclein
 
(72). Moreover the detections of many glycosylated proteins in exosomes suggest that glycosylation 
may also have a role in exosomal sorting, despite this needs to be further investigated
 
(68). Finally 
ISGylation, a PTM consisting in the addition of the small ubiquitin-like protein ISG15, has been 
recently shown to negatively regulate exosome release
 
(73), although it would rather act on the sorting 
machinery and the fate of the MVE than on the cargoe itself. 
In addition to PTM, protein cargoes can go through proteolytic cleavage before being incorporated into 
exosomes. Heparanase, the only mammalian enzyme able to cleave heparan sulfate internally, was 
identified as a stimulator of the syndecan-syntenin-ALIX pathway
 
(74). Indeed, endosomal heparanase 
trims the heparan sulfate side chains of syndecans. Such trimming would favor clustering of syndecan 
and its proteolytic processing to generate “SDC-CTF” that is sorted to ILVs. Such processing may 
reinforce syndecans-syntenin interaction therefore favouring ILV budding. Similar coordination 
between processing and sorting is well illustrated in melanocytes with the protein PMEL (75). PMEL is 
cleaved by the secretase BACE2 at the limiting membrane of pigment cell specific MVE. The two 
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cleavage products of PMEL, its luminal domain and PMEL-CTF are taken in charge by distinct sorting 
machinery within the same compartment. While PMEL-CTF is sequestered in an ESCRT-dependent 
manner into the clathrin coat at the limiting membrane of the compartment and destined for lysosomal 
degradation, the luminal amyloidogenic domain of PMEL is loaded on the surface of ILVs
 
(55)
  
and can 
be secreted on exosomes
 
(56)
 
in a CD63 –dependent manner. Despite the role of CD63 in the loading 
of luminal domain of PMEL into ILVs is still not completely clear, depletion of CD63 induces the 
targeting of full length PMEL to the ESCRT dependent pathway, suggesting that this tetraspanin is a 
key coordinator of the interrelated processing and sorting of cargoes fated for exosomal release.  
One can expect that the recruitment and the contribution of these different sorting pathways in 
exosomes biogenesis are not only dependent on the PTM or processing of the cargo to be sorted but 
will also depend on the cell type, the cellular homeostasis and the pathological conditions. But any 
enzymes involved in the modification or the processing of the exosomal cargoes can be considered as 
a regulator of exosomes biogenesis.  
 
BALANCE BETWEEN DEGRADATION AND SECRETION OF MVEs 
The main fate of a MVE is to fuse with lysosomes to degrade its content. Therefore MVEs must avoid 
lysosomal degradation in order to release their ILVs as exosomes. Several studies in which inhibition 
or blocking of lysosomal function induces exosome secretion support the hypothesis of the existence 
of a balance between lysosomal degradation and exosome secretion. For instance, treatment with 
Bafilomycin A1, a lysosome inhibitor, increases EV secretion
 
(73)
 
74)
 
or exosomal secretion of specific 
cargoes such as α-synuclein
 
(77). On the same line, inhibition of V-ATPase in Caenorhabditis elegans 
has been shown to trigger apical secretion of Hedgehog protein
 
(78). Such balance seems to be highly 
relevant in pathological conditions where lysosome activity is affected such as lysosomal storage 
diseases or neurodegenerative diseases. For instance, Niemann-Pick Type C (NPC) disease is 
caused by mutation in the cholesterol transporter NPC1 and is characterized by accumulation of 
cholesterol in endosomes and lysosomes. One study showed that NPC1 mutations or inhibition with 
drugs (U18666A) enhance secretion of cholesterol in exosomes (79), confirming, as shown in the first 
studies on exosomes (80), that exosomes is a way to eliminate compounds, such as cholesterol, that 
accumulate in the cell. Neurodegenerative diseases are often characterized by an impairment of 
lysosome function and an intracellular accumulation of toxic protein has been proposed to provoke 
their secretion extracellularly (81). For instance, accumulations of APP fragments Aβ and Tau are 
typical features of Alzheimer disease (AD) and both proteins were found in EVs released from AD cell 
culture models, in EVs isolated from CSF, brain extracellular space, and blood samples from AD 
patients (82,83). There is, so far, no direct evidence of a causal connection between intracellular 
accumulation and the release of these pathological proteins in EVs, but such pathway would certainly 
compensate for their impaired degradation inside the cells and therefore contribute to the maintenance 
of cellular homeostasis.  
Mechanisms that prevent lysosomal degradation in favor of exosome secretion provide then a 
powerful checkpoint to regulate exosomes biogenesis but they remain yet poorly understood (81). As 
suggested before, endosomal sorting machineries seems to drive MVEs either to secretion or to 
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lysosomal degradation. New regulators of sorting machineries at MVEs reinforce their regulatory role 
in the balance between secretion and degradation. ISGylation of TSG101 (73)
 
inhibits exosome 
secretion while mutations that impair ISGylation enhance exosome secretion. Such regulation is 
counterbalanced by the fusion of MVE with lysosomes establishing a first mechanism that can decide 
the fate of an MVE between fusion with lysosomes and fusion with PM. It also supports the notion that 
the first subunits of the ESCRT machinery can be employed in secretory and degradative MVEs, it 
would be then interesting to know whether ISGylation of TSG101 is determinant to recruit either 
conventional ESCRT machinery for degradation or ALIX for secretion. The tetraspanin 6 (TSPAN6) 
has also being recently involved in the regulation of this balance between lysosomal degradation and 
exosomal secretion. Overexpression of TSPAN6 slows down lysosomal degradation of APP-CTF and 
enhances its secretion on exosomes likely by recruiting syntenin (84). It remains also to determine if, 
in a cell type dependent manner, there is a clear separation of ESCRT-dependent and ESCRT-
independent sorting associated with distinct subsets of endosomes fated respectively to degradation 
and secretion.  
How then a given sorting can act on the motility and the targeting of a subpopulation of MVE? If both 
pathway can act concomitantly on the same MVE, one can propose that the aboundance of a given 
cargo or its PTM will favor the recruitment of one sorting mechanism rather than other and dictate the 
fate of MVE. Finally, as observed in specialized cells such as melanocytes, ESCRT-independent and 
ESCRT dependent could act sequentially, ESCRT independent acting first while cargoes fated for 
ESCRT dependent sorting are sequestered into clathrin coat at the limiting membrane. Only early 
MVE would be then able to be targeted for secretion. The cell type and its maturation state would be 
of importance as shown for dendritic cells that use different sorting mechanisms according to their 
maturation stage and reticulocytes that use different mechanisms for exosome secretion during their 
maturation into erythrocytes. Finally the only feature that has allowed to discriminate subpopulations of 
MVEs with apparent distinct fate is their content in cholesterol (85). 
In addition to lysosomes, MVEs can fuse with autophagosomes forming an amphisome (86). This 
organelle will then fuse with lysosome in order to allow the degradation of their content, in a process 
called macroautophagy. Therefore, a similar balance between exosome secretion and autophagy may 
exist and would be dependent on external stimuli such as starvation. Supporting this hypothesis, it has 
been shown that the prion protein (PrP) can promote exosome secretion by inhibiting autophagosome 
formation through interaction with caveolin 1, a suppressor of autophagosome formation
 
(87). 
Moreover, inhibition of the kinase PIKfyve, that is also involved in autophagy, increase secretion of a 
subpopulation of “autophagic” exosomes enriched in autophagic proteins but not in “classical 
exosomal markers”, again suggesting that impairment of autophagy can be balanced by secretion
 
(88). 
Interestingly different autophagy proteins have recently been shown to regulate exosome secretion, 
such as ATG12-ATG3 complex that control both autophagy and exosome secretion through 
interaction with ALIX (89), or ATG5 which induces sequestration of a subunit of V1V0-ATPase in ILV 
inhibiting ATPase activity and therefore promoting MVEs acidification and exosome secretion
 
(37). 
Additionally, the tetraspanin CD63 has recently been proposed to coordinate both autophagic and 
endosomal processes and to regulate exosomal secretion of Epstein-Barr virus-encoded LMP1 (90). 
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Finally, it is noteworthy that not only MVEs but also lysosomes and autolysosomes can secrete their 
content in the extracellular environment, included remaining ILVs. Despite these pathways could use 
different machineries, they cannot be entirely separated but they can all contribute to maintain cell 
homeostasis. 
 
TARGETING MVE TO THE PLASMA MEMBRANE FOR SECRETION 
Regardless of their fate, MVEs have to be transported before fusing with lysosomes or plasma 
membrane. In general intracellular transport of organelles requires association to the cytoskeleton 
together with the action of molecular motors and small GTPases, and their fusion involves SNARE 
proteins (91,92). In this emerging topic, the precise role of these machineries involved in exosome 
secretion would benefit from further investigations to be clearly understood.  
Several RAB proteins have been involved in exosome secretion. For instance, use of a dominant 
negative mutant of RAB11, a GTPase mostly known for its role in recycling of cargoes from EE to PM, 
decreases secretion of TfR and HSC70 in exosomes from leukemia cell line K562
 
(93); while in 
Drosophila S2 cells, RAB11 depletion inhibits secretion of EVs bearing wingless
 
(94) or Evi
 
(95). In 
addition, depletion of either RAB11 or RAB35 in retinal epithelial cells, decreases exosomal secretion 
of flotillin and anthrax toxin
 
(96). Other studies confirmed the involvement of RAB35 in exosome 
secretion from primary oligodendrocytes
 
(97) or oligodendroglial cell line, where RAB35 seems to have 
a role in the docking and tethering of MVEs to the plasma membrane
 
(98)
 
. An shRNA based screen in 
HeLa cells expressing MHC class II molecules showed that silencing of RAB2B, RAB5A, RAB9A, 
RAB27A and RAB27B decreased CD63, CD81, and MHC class II secretion on exosomes (7). More in 
detail, the same study shows the involvement of RAB27A/B in the docking of MVBs to the PM and 
several following studies have confirmed in different cell lines the reduction in exosome secretion after 
RAB27A silencing and this strategy is now commonly used as a way to modulate exosome 
secretion(45,99–101). Finally, RAB7 has been involved in secretion of syntenin-ALIX exosomes by 
MCF7 tumors (12), whereas its depletion does not affect exosome secretion in HeLa cells (7). The fact 
that both early and late endosomal Rab proteins have a role in exosome secretion suggests that, 
according to the cell type, different subpopulations of MVEs originating from either early or recycling 
endosomes or from late endosomes are employed to release ILVs as exosomes. Alternatively, the 
involvement of so many RABs protein acting on the various compartments that scatter the endosomal 
pathway would suggest the interdependency of the different steps controlling the endosomal pathway 
in the regulation of exosomes biogenesis.  
The importance of the cytoskeleton is supported by the specific location of the release of exosomes at 
the plasma membrane as in the case of immunological synapses in antigen presenting cells (69,102) 
or invadopodia
 
(45) in cancer cells. The microtubules network would be of prime importance to 
transport MVEs to the site of secretion in coordination with molecular motor. RAB7 is a key regulator 
of MVEs motility as it can interact with dynein motor through its effector RILP favoring the transport of 
late endosomes toward the microtubules organizing center (MTOC)
 
(103) where lysosomes localize. 
Such interaction is regulated by the ubiquitination state of RAB7 (33)
 
and the presence of cholesterol 
in the limiting membrane of MVEs
 
(104). This suggests that the composition of the limiting membranes 
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of MVEs may modulate the fate of these MVEs by acting on the motility of MVEs. It would also shed 
new light on the relationship between the fate of MVEs and the associated endosomal sorting 
machineries that modify the composition of the limiting membrane of MVEs by generating ILVs. Actin 
cytoskeleton would also affect exosome release as it is required for the docking and the fusion of 
MVEs with the plasma membrane. Actin regulatory protein cortactin has been shown to promote 
exosome secretion by regulating both trafficking and docking of MVEs to the plasma membrane 
together with the small RAB GTPase RAB27A and coronin1b
 
(105). At this step, the machineries 
involved in docking and fusion of MVEs with PM are still not completely known, although some RAB 
GTPases, SNARE proteins and synaptogamin family members participating in this process have been 
identified. As previously mentioned, RAB27A and RAB27B (together with their respective effectors, 
synaptotagmin-like protein 4 and exophilin 5) act in the docking of MVEs to PM in order to promote 
their fusion
 
(7) and this mechanism requires the rearrangement of actin cytoskeleton (105). The 
SNARE protein VAMP7 has been involved in exosome secretion in leukemia cell line K562
 
(106) and 
expression of a form of VAMP7 that inhibits SNARE complex formation decrease exosome secretion. 
Another SNARE, YKT6 has been shown to be required for exosome release in HEK239 cells
 
(36) and 
in A549 lung cancer cells
 
(107). In C. elegans the Ras-related GTPase homolog Ral-1 is involved in 
MVEs biogenesis and in their fusion with PM together with the SNARE syntaxin 5 (108). Recently 
phosphorylated SNAP23 has been shown to enable exosome release
 
(66,109). Of note, new tools to 
directly vizualise exosomes secretion in live cells, such as CD63-pHluorin, open new avenues to map 
and understand the release of exosomes at the scale of a single cell. In this context, the release Ca
2+
 
in the cytoplasm seems differently required for the activation of SNARE complexzq involved in MVE-
PM fusion, revealing cell type specific contribution of this know regulator of exosome secretion 
(66,110–112). This last checkpoint is determinant in exosomes function, as it will orientate exosomes 
secretion toward the right cellular partner of a synapse (69) or toward the right body fluids or biological 
barrier to reach its final destination. 
 
CONCLUSION 
The multiple checkpoints that have been described here as potential regulator of the biogenesis of 
exosomes are all subjected to regulatory pathways that can be stimulated or inhibited under 
physiological or pathological conditions (113). This implies that exosomes biogenesis and secretion 
are likely more part of an inducible pathway that is modulated according to the stimuli received by the 
producing cells than a constitutive pathway. Once released in the extracellular space exosomes can 
reach body fluids such as blood that travel through the whole body supporting their targeting to 
destinations very far from their site of production. Alternatively, exosomes can stay closely associated 
to the cells that produced them through a mechanism that requires presence of tetherin
 
(76). The 
machineries involved in the biogenesis of exosomes, by modulating their composition, will be then 
critical to specify their uptake by receiving cell types or to regulate their destination, as shown in vivo 
for tumor exosomes that can reach and stop in different organs according to the set of integrins they 
contain
 
(114). Once at destination, the machineries that have been involved in their biogenesis in 
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producing cells will be also determinant in recipient cells to modulate exosome fate and to induce 
signaling cascade or to provide a trophic support.  
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Figure Legends. 
Figure 1: Intracellular trafficking checkpoints involved in exosome biogenesis.  
Letters in white squares indicate the different checkpoints. Blue arrows highlight the trafficking steps 
favoring exosome bioegenesis and the red arrows the trafficking steps impairing exosome biogenesis. 
Green arrows represents alternative release mechanisms. Exosomal cargoes reach endosomal 
compartment through endocytosis or by direct transport from Golgi apparatus (a and a’). Before being 
sorted into ILVs the cargo need to avoid recycling to PM or Golgi (b and b’). Once formed (c and 
Figure 2), MVEs have to escape different fates such as fusion with lysosomes or autophagosomes (d) 
and be transported toward the plasma membrane in order to fuse with it and secrete exosomes in the 
extracellular environment (e). Main reported regulators of each step are indicated at each regulatory 
step. 
Figure 2: Sorting mechanisms at MVE involved in exosome biogenesis.  
Bold arrows outside of the MVE indicate the main sorting mechanisms reported so far. Dashed arrows 
within the lumen of MVE propose potential intersection or coodination between sorting mechanisms. 
Four main sorting mechanisms has been reported so far for transmembrane proteins, the classical 
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ESCRT machinery (a), the tetraspanin microdomains (b), the syntenin/Alix pathway (c) and the 
Ceramide pathway. Posttranslational modifications are key regulators allowing controlled targeting of a 
modified cargoe (ubiquitination, cleavage) to a specific sorting mechanisms (e and e’).  
 
Figure 3: The balance between degradation and secretion of MVEs. 
A key checkpoint in the secretion of exosomes is the balance between lysosomal degradation of MVE 
and their targeting to the plasma membrane for secretion. Reported regulators influencing each scale 
of the balance are indicated. Of note it remains to be determined if targeting toward degradation or 
secretion is regulated by the generation of distinct subpopulations of MVEs by abundance of a given 
cargoe or recruitment of distincts sorting mechanisms, by the maturation of the MVE or by 
posttraductional modification of MVE associated proteins. Such balance is notably important in 
lysosome storage disorder and amyloid associated neurodegenerative diseases. 
 



